Description:Healthcare professionals and patients should use this application to search for potential drug-drug interactions between hepatitis drugs and other medications, as recommended by international treatment guidelines. Results are presented as a Traffic Light system (red, amber, green) to indicate the recommendation. A brief summary of each interaction is given. The application is available free of charge and has been developed by the Liverpool Drug Interactions Group at the University of Liverpool and Podmedics. Requirements:This is an offline application that is downloaded to your device (~12.2 MB). An internet connection is not required to use the application, but is needed for downloading updates.Why this application may be useful:In hepatitis therapy, patients take more than one hepatitis medication at a time and possibly other drugs to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different hepatitis drugs and other medications that the HCV- and/or HBV-infected patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at application is based on the original HEP iChart app but has been updated for iOS8 compatibility as well as providing universal support for both iPhones and iPads.
File Size3.6 MB
Operating System iOS
System RequirementsCompatible with: iphone4, iphone4, ipad2wifi, ipad2wifi, ipad23g, ipad23g, iphone4s, iphone4s, ipadthirdgen, ipadthirdgen, ipadthirdgen4g, ipadthirdgen4g, iphone5, iphone5, ipodtouchfifthgen, ipodtouchfifthgen, ipadfourthgen, ipadfourthgen, ipadfourthgen4g, ipadfourthgen4g, ipadmini, ipadmini, ipadmini4g, ipadmini4g


You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
See All
See All